Skip to content

C7A.011 ICD-10-CM Code: Malignant carcinoid tumor of the jejunum

C7A.011 maps to CMS-HCC V28 21 (RAF 0.671). Documentation must support MEAT. MEAT criteria · RAF calculator · HCC coding software

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neuroendocrine tumors (C7A)

C7A.011

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Malignant carcinoid tumor of the jejunum

A rare cancer that develops in hormone-producing cells of the jejunum, which is the middle section of the small intestine.

Buddy the Bee presenting code insight

Buddy Insight

Malignant carcinoid tumor of the jejunum is a neuroendocrine neoplasm arising in the middle segment of the small intestine.

CMS-HCC V28

HCC 21

RAF 0.671

CMS-HCC V24

HCC 12

RAF 0.150

ACA/HHS

HCC 12

Varies by metal level

ESRD/PACE

HCC 12

RAF 0.045

RXHCC

HCC 22

RAF 0.124

Code Book Path

Official
C7A.0Malignant carcinoid tumors
C7A.01Malignant carcinoid tumors of the small intestine
C7A.011Malignant carcinoid tumor of the jejunum

Inclusion Terms

Official

ICD-10-CM does not list inclusion terms for C7A.011 in this effective period.

Excludes 2

Official

ICD-10-CM does not list Excludes 2 notes for C7A.011 in this effective period.

Related Child Codes

Official
C7A.010Malignant carcinoid tumor of the duodenum
C7A.012Malignant carcinoid tumor of the ileum
C7A.019Malignant carcinoid tumor of the small intestine, unspecified portion

Includes

Official

ICD-10-CM does not list Includes notes for C7A.011 in this effective period.

Excludes 1

Official

ICD-10-CM does not list Excludes 1 notes for C7A.011 in this effective period.

Code First

Official

ICD-10-CM does not list Code First sequencing instructions for C7A.011 in this effective period.

Use Additional

Official

ICD-10-CM does not list Use Additional Code instructions for C7A.011 in this effective period.

Code Also

Official

ICD-10-CM does not list Code Also instructions for C7A.011 in this effective period.

Buddy Documentation Tip

HCC Buddy guidance
Pathological confirmation of neuroendocrine differentiation with malignant behavior
Tumor grade — Ki-67 index and mitotic count per WHO classification
Tumor size and depth of invasion
Staging — lymph node involvement and distant metastases (especially liver)

MEAT Support

HCC Buddy guidance
Pathological confirmation of neuroendocrine differentiation with malignant behavior
Tumor grade — Ki-67 index and mitotic count per WHO classification
Tumor size and depth of invasion
Staging — lymph node involvement and distant metastases (especially liver)

Audit Caution

HCC Buddy guidance
Using unspecified small intestine code when jejunum is specifically documented in operative or pathology reports
Confusing jejunal adenocarcinoma with jejunal carcinoid — histological type determines the code category
Not checking for liver metastases (C7B.02) which are common at presentation for small bowel carcinoids
Failing to code carcinoid syndrome (E34.0) or carcinoid heart disease (I36.1) when present

Common Mistakes

HCC Buddy guidance
C7A.010 — Malignant carcinoid tumor of duodenum; the jejunum is distal to the duodenum and requires different coding
C7A.012 — Malignant carcinoid tumor of ileum; distinguish jejunal from ileal location based on surgical or pathological findings
C7A.019 — Malignant carcinoid tumor of small intestine, unspecified; use C7A.011 when jejunum is confirmed
C17.1 — Primary malignant neoplasm of jejunum; adenocarcinoma uses C17 codes, not C7A codes

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is C7A.011 an HCC code?

Yes. C7A.011 (Malignant carcinoid tumor of the jejunum) maps to Lymphoma and Other Cancers under the CMS-HCC V28 risk adjustment model (and Breast, Prostate, and Other Cancers and Tumors under V24), with a community non-dual aged RAF of 0.671. It is billable for payment year 2026.

Coder answer: C7A.011 is billable and maps to V28 HCC 21, Lymphoma and Other Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code
C7A.011
Description
Malignant carcinoid tumor of the jejunum
HCC (V28)
HCC 21 — Lymphoma and Other Cancers
RAF
0.671
Billable
Yes
Payment year
2026

HCC Category Mapping

V28HCC 21, Lymphoma and Other Cancers
0.671
V24HCC 12, Breast, Prostate, and Other Cancers and Tumors
0.150
ESRDHCC 12, Breast, Prostate, and Other Cancers and Tumors
0.045
RxHCCHCC 22, Cancer, Other Specified Sites
0.124

Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.

Work C7A.011 in the Code Book — tabular path, V28 RAF, and MEAT checklist →

MEAT Criteria for C7A.011

For C7A.011 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C7A.011 during that encounter, not just copy-forwarded from a problem list.

Coder workflow notes

Get the V28 RAF + MEAT cheat sheet

One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

C7A.011 is the ICD-10-CM diagnosis code for malignant carcinoid tumor of the jejunum. A rare cancer that develops in hormone-producing cells of the jejunum, which is the middle section of the small intestine. C7A.011 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neuroendocrine tumors (c7a).

Under the CMS-HCC V28 risk adjustment model, C7A.011 maps to Lymphoma and Other Cancers (HCC 21) with a community, non-dual, aged base RAF weight of 0.671. Under the older CMS-HCC V24 model, C7A.011 maps to Breast, Prostate, and Other Cancers and Tumors (HCC 12) with a community, non-dual, aged base RAF weight of 0.150. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.

The jejunum is the middle portion of the small intestine; ensure documentation clearly specifies this location. Because C7A.011 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C7A.011 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • The jejunum is the middle portion of the small intestine; ensure documentation clearly specifies this location
  • Carcinoid tumors of the small intestine often have metastasized by diagnosis, so check for secondary site codes

Clinical Significance

Malignant carcinoid tumor of the jejunum is a neuroendocrine neoplasm arising in the middle segment of the small intestine. Jejunal carcinoids are midgut tumors more likely to cause carcinoid syndrome than foregut tumors, especially when liver metastases are present. They often present late with abdominal symptoms, bowel obstruction, or carcinoid syndrome.

Documentation Requirements

  • Pathological confirmation of neuroendocrine differentiation with malignant behavior
  • Tumor grade — Ki-67 index and mitotic count per WHO classification
  • Tumor size and depth of invasion
  • Staging — lymph node involvement and distant metastases (especially liver)
  • Functional status — 24-hour urinary 5-HIAA, chromogranin A levels
  • Presence of carcinoid syndrome symptoms

Commonly Confused Codes

  • C7A.010: Malignant carcinoid tumor of duodenum; the jejunum is distal to the duodenum and requires different coding
  • C7A.012: Malignant carcinoid tumor of ileum; distinguish jejunal from ileal location based on surgical or pathological findings
  • C7A.019: Malignant carcinoid tumor of small intestine, unspecified; use C7A.011 when jejunum is confirmed
  • C17.1: Primary malignant neoplasm of jejunum; adenocarcinoma uses C17 codes, not C7A codes

Child Codes

Code Hierarchy

Because C7A.011 maps to a payment HCC, the documentation must also satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's risk adjustment score.

C7A.011 maps to CMS-HCC V28 category 21, Lymphoma and Other Cancers. See the ICD-10 to HCC mapping hub for how the V28 crosswalk works. Because C7A.011 carries a payment HCC, you can see what it adds to a RAF score and check the documentation the chart needs before it is submitted.

Work C7A.011 in HCC Buddy

Open C7A.011 in the Code Book for the full Index-to-Tabular path, MEAT checklist, and V28 HCC mapping, or in the Encoder to code from a keyword search. Pro includes 7 days to try everything, no card required.